Pharma Marketing by 2030 – Asrar Qureshi’s Blog Post #1148
Pharma Marketing by 2030 – Asrar Qureshi’s Blog Post #1148 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1148 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com for publishing your contributions here. Credit: Timur Saglambilek Credit: Mikael Blomkvist Preamble I discussed how pharmaceutical selling is likely to change during the next five years. Now, this is a broad vision of how pharmaceutical marketing may look like by 2030, with a special lens on Pakistan. It is more complex than selling because marketing is the brain and it works for present and future simultaneously. What will change materially by 2030 Omnichannel becomes the default, not “digital vs. rep,” but both. HCPs increasingly want integrated experiences across rep visits, virtual touchpoints, portals, webinars, medical content hubs, and peer channels. Medical and commercial touchpoints will be o...
